Cost utility analysis of a collaborative stepped care intervention for panic and generalized anxiety disorders in primary care

Journal of Psychosomatic Research

Volumn 77, Issue 1, 2014, Pages 57-63

  Goorden, Maartje ^a   Muntingh, Anna ^b,d,e   van Marwijk, Harm ^e,f   Spinhoven, Philip ^g,h   Adèr, Herman ⁱ   van Balkom, Anton ^e   van der Feltz Cornelis, Christina ^b,c,d   Hakkaart van Roijen, Leona ^a  

^a ERASMUS UNIVERSITY ROTTERDAM   (Netherlands)

^b NETHERLANDS INSTITUTE OF MENTAL HEALTH AND ADDICTION   (Netherlands)

^c GGz Breburg   (Netherlands)

^d TILBURG UNIVERSITY   (Netherlands)

^e VU UNIVERSITY MEDICAL CENTER   (Netherlands)

^f UNIVERSITY OF AMSTERDAM   (Netherlands)

^g LEIDEN UNIVERSITY   (Netherlands)

^h LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

ⁱ Johannes van Kessel Advising   (Netherlands)

Author keywords

Anxiety; Cost utility; Panic; Randomized trial; Societal perspective; Stepped care

Indexed keywords

ADULT; ARTICLE; COLLABORATIVE STEPPED CARE; CONTROLLED STUDY; COST EFFECTIVENESS ANALYSIS; COST UTILITY ANALYSIS; FEMALE; FOLLOW UP; GENERALIZED ANXIETY DISORDER; HEALTH CARE PERSONNEL; HEALTH CARE UTILIZATION; HUMAN; MAJOR CLINICAL STUDY; MALE; MENTAL HEALTH CARE; NETHERLANDS; OUTCOME ASSESSMENT; PANIC; PATIENT CARE; PRIMARY MEDICAL CARE; PRODUCTIVITY; QUALITY ADJUSTED LIFE YEAR; RANDOMIZED CONTROLLED TRIAL; STUDY DESIGN;

ANXIETY; COST UTILITY; PANIC; RANDOMIZED TRIAL; SOCIETAL PERSPECTIVE; STEPPED CARE;

ANXIETY DISORDERS; COOPERATIVE BEHAVIOR; COST-BENEFIT ANALYSIS; FEMALE; HUMANS; MALE; MIDDLE AGED; NETHERLANDS; PANIC DISORDER; PRIMARY HEALTH CARE; QUALITY OF LIFE;

EID: 84901987304     PISSN: 00223999     EISSN: 18791360     Source Type: Journal    
DOI: 10.1016/j.jpsychores.2014.04.005     Document Type: Article

References (51)

1. Kroenke K, Spitzer RL, Williams JB, Monahan PO, Lowe B Anxiety disorders in primary care: prevalence, impairment, comorbidity, and detection. Ann Intern Med 2007, 146:317-325.
2. Roy-Byrne PP, Wagner A Primary care perspectives on generalized anxiety disorder. J Clin Psychiatry 2004, 65:20-26.
3. Lieb R, Becker E, Altamura C The epidemiology of generalized anxiety disorder in Europe. Eur Neuropsychopharmacol 2005, 15:445-452.
4. Roy-Byrne PP, Wagner AW, Schraufnagel TJ Understanding and treating panic disorder in the primary care setting. J Clin Psychiatry 2005, 66:16-22.
5. Olatunji BO, Cisler JM, Tolin DF Quality of life in the anxiety disorders: a meta-analytic review. Clin Psychol Rev 2007, 27:572-581.
6. Beard C, Weisberg RB, Keller MB Health-related quality of life across the anxiety disorders: findings from a sample of primary care patients. J Anxiety Disord 2010, 24:559-564.
7. Bereza BG, Machado M, Einarson TR Systematic review and quality assessment of economic evaluations and quality-of-life studies related to generalized anxiety disorder. Clin Ther 2009, 31:1279-1308.
8. Barrera TL, Norton PJ Quality of life impairment in generalized anxiety disorder, social phobia, and panic disorder. J Anxiety Disord 2009, 23:1086-1090.
9. Andlin-Sobocki P, Wittchen HU Cost of anxiety disorders in europe. J Clin Psychiatry 2002, 12:39-44.
10. Roy-Byrne P, Russo J, Dugdale DC, Lessler D, Cowley D, Katon W Undertreatment of panic disorder in primary care: role of patient and physician characteristics. J Am Board Fam Pract 2002, 15:443-450.
11. Stein MB, Sherbourne CD, Craske MG, Means-Christensen A, Bystritsky A, Katon W, et al. Quality of care for primary care patients with anxiety disorders. Am J Psychiatry 2004, 161:2230-2237.
12. Stein MB, Roy-Byrne PP, Craske MG, Campbell-Sills L, Lang AJ, Golinelli D, et al. Quality of and patient satisfaction with primary health care for anxiety disorders. J Clin Psychiatry 2011, 72:970-976.
13. Fernandez A, Haro JM, Martinez-Alonso M, Demyttenaere K, Brugha TS, Autonell J, et al. Treatment adequacy for anxiety and depressive disorders in six european countries. Br J Psychiatry 2007, 190:172-173.
14. Smolders M, Laurant M, Roberge P, van Balkom A, van Rijswijk E, Bower P, et al. Knowledge transfer and improvement of primary and ambulatory care for patients with anxiety. Can J Psychiatry 2008, 53:277-293.
15. Heuzenroeder L, Donnelly M, Haby MM, Mihalopoulos C, Rossell R, Carter R, et al. Cost-effectiveness of psychological and pharmacological interventions for generalized anxiety disorder and panic disorder. Aust N Z J Psychiatry 2004, 38:602-612.
16. Prins MA, Verhaak PF, van der Meer K, Penninx BW, Bensing JM Primary care patients with anxiety and depression: need for care from the patient's perspective. J Affect Disord 2009, 119:163-171.
17. Walters K, Buszewicz M, Weich S, King M Help-seeking preferences for psychological distress in primary care: effect of current mental state. Br J Gen Pract 2008, 58:694-698.
18. van Schaik DJ, Klijn AF, van Hout HP, van Marwijk HW, Beekman AT, de Haan M, et al. Patients' preferences in the treatment of depressive disorder in primary care. Gen Hosp Psychiatry 2004, 26:184-189.
19. Nadiga DN, Hensley PL, Uhlenhuth EH Review of the long-term effectiveness of cognitive behavioral therapy compared to medications in panic disorder. Depress Anxiety 2003, 17:58-64.
20. Katon W, Von Korff M, Lin E, Simon G Rethinking practitioner roles in chronic illness: the specialist, primary care physician, and the practice nurse. Gen Hosp Psychiatry 2001, 23:138-144.
21. Bakker IM, van Marwijk HW, Terluin B, Anema JR, van Mechelen W, Stalman WA Training GP's to use a minimal intervention for stress-related mental disorders with sick leave (MISS): effects on performance: results of the MISS project; a cluster-randomised controlled trial [ISRCTN43779641. Patient Educ Couns 2010, 78:206-211.
22. Bower P, Gilbody S Stepped care in psychological therapies: access, effectiveness and efficiency. narrative literature review. Br J Psychiatry 2005, 186:11-17.
23. Roy-Byrne PP, Katon W, Cowley DS, Russo J A randomized effectiveness trial of collaborative care for patients with panic disorder in primary care. Arch Gen Psychiatry 2001, 58:869-876.
24. Roy-Byrne PP, Craske MG, Stein MB, Sullivan G, Bystritsky A, Katon W, et al. A randomized effectiveness trial of cognitive-behavioral therapy and medication for primary care panic disorder. Arch Gen Psychiatry 2005, 62:290-298.
25. Rollman BL, Belnap BH, Mazumdar S, Houck PR, Zhu F, Gardner W, et al. A randomized trial to improve the quality of treatment for panic and generalized anxiety disorders in primary care. Arch Gen Psychiatry 2005, 62:1332-1341.
26. Roy-Byrne P, Craske MG, Sullivan G, Rose RD, Edlund MJ, Lang AJ, et al. Delivery of evidence-based treatment for multiple anxiety disorders in primary care: a randomized controlled trial. JAMA 19 2010, 303:1921-1928.
27. Muntingh ADT, van der Feltz-Cornelis CM, van Marwijk HWJ, Spinhoven P, Assendelft WJJ, de Waal MWM, et al. Effectiveness of collaborative stepped care for anxiety disorders in primary care: a pragmatic cluster randomized controlled trial. Psychother Psychosom 2013, 83:37-44.
28. van Steenbergen-Weijenburg KM, van der Feltz-Cornelis CM, Horn EK, van Marwijk HW, Beekman AT, Rutten FF, et al. Cost-effectiveness of collaborative care for the treatment of major depressive disorder in primary care. A systematic review. BMC Health Serv Res 2010, 19:10:19.
29. Jacob V, Chattopadhyay SK, Sipe TA, Thota AB, Byard GJ, Chapman DP Community Preventive Services Task Force. Economics of collaborative care for management of depressive disorders: a community guide systematic review. Am J Prev Med 2012, 42:539-549.
30. Joesch JM, Sherbourne CD, Sullivan G, Stein MB, Craske MG, Roy-Byrne P Incremental benefits and cost of coordinated anxiety learning and management for anxiety treatment in primary care. Psychol Med 2011, 13:1-12.
31. Katon W, Russo J, Sherbourne C, Stein MB, Craske M, Fan MY, et al. Incremental cost-effectiveness of a collaborative care intervention for panic disorder. Psychol Med 2006, 36:353-363.
32. Katon WJ, Roy-Byrne P, Russo J, Cowley D Cost-effectiveness and cost offset of a collaborative care intervention for primary care patients with panic disorder. Arch Gen Psychiatry 2002, 59:1098-1104.
33. Muntingh AD, van der Feltz-Cornelis CM, van Marwijk HW, Spinhoven P, Assendelft WJ, de Waal MW, et al. Collaborative stepped care for anxiety disorders in primary care: aims and design of a randomized controlled trial. BMC Health Serv Res 2009, 8:9:159.
34. Spitzer RL, Kroenke K, Williams JB Validation and utility of a self-report version of PRIME-MD: the PHQ primary care study. Primary care evaluation of mental disorders. Patient Health Questionnaire. JAMA 10 1999, 282:1737-1744.
35. van Vliet I.M., Leroy H., van Megen H.J.M. De MINI-internationaal neuropsychiatrisch interview: Een kort gestructureerd diagnostisch interview voor DSM-IV en ICD-10. psychiatrische stoornissen 2000.
36. van Boeijen CA, van Oppen P, van Balkom AJ, Visser S, Kempe PT, Blankenstein N, et al. Treatment of anxiety disorders in primary care practice: a randomised controlled trial. Br J Gen Pract 2005, 55:763-769.
37. Terluin B, van Marwijk HW, Ader HJ, de Vet HC, Penninx BW, Hermens ML, et al. The four-dimensional symptom questionnaire (4DSQ): a validation study of a multidimensional self-report questionnaire to assess distress, depression, anxiety and somatization. BMC Psychiatry 2006, 22:6:34.
38. Beck AT, Epstein N, Brown G, Steer RA An inventory for measuring clinical anxiety: psychometric properties. J Consult Clin Psychol 1988, 56:893-897.
39. Terluin B, Van Heest FB, Van der Meer K, Neomagus GJH, Hekman J, Aulbers LPJ, et al. NHG-standaard angststoornissen. Huisarts En Wetenschap 2004, 47:26-37.
40. Hakkaart-van Roijen L Manual Trimbos/iMTA questionnaire for costs associated with psychiatric illness (in dutch). J Consult Clin Psychol 2002, 59:12-19.
41. Oostenbrink JB, Bouwmans CAM, Koopmanschap MA Handleiding voor kostenonderzoek, methoden en standaardkostprijzen voor economische evaluaties in de gezondheidszorg (manual for research on costs, methods and standardized cost prices for economic evaluation in health care) 2004.
42. Hakkaart-van Roijen L, Tan SS, Bouwmans CAM Handleiding voor kostenonderzoek: Methoden en standaard kostprijzen voor economische evaluaties in de gezondheidszorg 2010, College voor zorgverzekeringen, Diemen.
43. van Roijen L, Essink-Bot ML, Koopmanschap MA, Bonsel G, Rutten FF Labor and health status in economic evaluation of health care. The Health and Labor Questionnaire. Int J Technol Assess Health Care 1996, 12:405-415.
44. Koopmanschap MA, Rutten FF, van Ineveld BM, van Roijen L The friction cost method for measuring indirect costs of disease. J Health Econ 1995, 14:171-189.
45. Cheung K, Oemar M, Oppe M, Rabin R Eq-5D user guide, basic information on how to use EQ-5D 2009, EuroQol Group.
46. Matthews JNS, Altman DG, Campbell MJ, Royston P Analysis of serial measurements in medical research. BMJ 1990, 300:230-235.
47. Koopmans GT, Lamers LM Is the impact of depressive complaints on the use of general health care services dependent on severity of somatic morbidity?. J Psychosom Res 2006, 61:41-50.
48. Prins M, Bosmans J, Verhaak P, van der Meer K, van Tulder M, van Marwijk H, et al. The costs of guideline-concordant care and of care according to patients' needs in anxiety and depression. J Eval Clin Pract 2011, 17:537-546.
49. Krol M, Papenburg J, Koopmanschap M, Brouwer W Do productivity costs matter?: the impact of including productivity costs on the incremental costs of interventions targeted at depressive disorders. Pharmacoeconomics 2011, 29:601-619.
50. Smit F, Cuijpers P, Oostenbrink J, Batelaan N, de Graaf R, Beekman A Costs of nine common mental disorders: implications for curative and preventive psychiatry. J Ment Health Policy Econ 2006, 9:193-200.
51. Scogin FR, Hanson A, Welsh D Self-administered treatment in stepped-care models of depression treatment. J Clin Psychol 2003, 59:341-349.